Firstpost | Gilead to license hepatitis C drug to lower-cost manufacturers in India Firstpost The World Health Organization estimates that about three percent of the world's population has been infected with the hepatitis C virus and that more than 170 million chronic carriers are at risk of developing liver cirrhosis, liver cancer or both ... |
